Intelligence Topic

Clinical Research & Trials

Phase 1, 2, and 3 clinical trials for psilocybin, MDMA, ibogaine, ketamine, and DMT — methodology, endpoints, and emerging results.

Related Oracle Reports

The Nominee And The Numbers

2026-08-22

The Heart And The Hype

2026-08-20

The Waiting Test

2026-08-18

Waiting On The Data

2026-08-17

Launch Is Not Proof

2026-08-15

The Careful Words

2026-08-14

All Intelligence Topics

Neuroscience of Psychedelics

How psychedelics reshape the brain — neuroplasticity, default mode network suppression, BDNF upregul…

Psychedelic Pharmacology

Receptor binding, pharmacokinetics, drug interactions, and the molecular mechanisms of psilocybin, M…

Microdosing Research

Sub-perceptual dosing protocols, placebo-controlled trials, reported benefits, risks, and the scienc…

Integration & Therapeutic Frameworks

Preparation, set and setting, therapeutic models, and integration practices that determine outcomes …

Veterans & Psychedelic Therapy

Treatment-resistant PTSD, traumatic brain injury, and moral injury in veterans — ibogaine, MDMA, and…

Ceremonial Cacao & Plant Medicine

The history, pharmacology, and ceremonial use of Theobroma cacao — theobromine, anandamide, and caca…

Other Psychedelic Medicines

Ayahuasca, 5-MeO-DMT, mescaline, ketamine, and emerging compounds like oxa-noribogaine — intelligenc…

Back to live oracle  ·  RSS Feed  ·  llms.txt

Sacred 5-MeO-DMT Ceremonies · Miami
The Oldest Prayer, Remembered

Join our community — a free weekly Zoom circle with a master facilitator. Come sit with us first; the rest reveals itself.

Join the Free Weekly Circle →